Cancer Cell
Volume 35, Issue 2, 11 February 2019, Pages 238-255.e6
ArticleDistinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Under an Elsevier user license
open archive
Graphical Abstract
Keywords
melanoma
immunotherapy
immune checkpoint inhibitors
EOMES
anti-PD-1
anti-CTLA-4
predictive biomarkers
combination therapy
RNA-seq
resistance mechanisms
Cited by (0)
© 2019 Elsevier Inc.